Table 2. Incidence of serious treatment-emergent adverse events occurring in ⩾2% of patientsa .
Patients, n (%)
|
|||
---|---|---|---|
No baseline resting tremor n=196 | Mild baseline resting tremor n=38 | Significant baseline resting tremor n=52 | |
Any serious adverse event | 62 (32) | 9 (24) | 21 (40) |
Complication of device insertion | 9 (5) | 3 (8) | 2 (4) |
Polyneuropathy | 6 (3) | 1 (3) | 1 (2) |
Parkinson’s disease | 4 (2) | 1 (3) | 3 (6) |
Pneumoperitoneum | 3 (2) | 1 (3) | 2 (4) |
Weight decreased | 1 (1) | 0 | 2 (4) |
Prostate cancer | 0 | 0 | 2 (4) |
Psychotic disorder | 0 | 0 | 2 (4) |
Adverse events could be coded to >1 preferred term. Preferred terms listed in descending order of patient incidence for the no baseline tremor subgroup.